Lesion Diameter Versus Inflammatory Biomarkers and Clinical Severity in Predicting Treatment Selection in Idiopathic Granulomatous Mastitis
Muhammet Fatih Keyif, Sabahattin Destek · 2026
Read Lesion Diameter Versus Inflammatory Biomarkers and Clinical Severity in Predicting Treatment Selection in Idiopathic Granulomatous Mastitis by Muhammet Fatih Keyif, Sabahattin Destek (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13662512.txt.
Description
Keyif and Destek ask what steers doctors toward surgery or medicine alone for a rare inflammatory breast disease, idiopathic granulomatous mastitis. Blood markers of inflammation have been proposed as guides, but lesion size is rarely weighed beside them. Their study covered 71 women with proven disease and 42 healthy controls.
Patients' blood counts and inflammation markers ran far above the controls'. Yet only one factor predicted who got surgery: the diameter of the lesion on ultrasound. Each extra millimeter raised the odds of surgery by about a fifth. Severity signs and blood markers added nothing once size was counted. The authors offer lesion size as the practical guide.
Catalog record
| CREATOR | Muhammet Fatih Keyif, Sabahattin Destek |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |